Want to join the conversation?
$IPXL said that it has received U.S. FDA's final approval for its generic version of Avodart (Dutasteride) capsules 0.5 mg on Nov. 20, 2015, which is used to treat benign prostatic hyperplasia in men with enlarged prostate. According to IMS Health, U.S. brand & generic sales of Dutasteride were about $457MM for 12 months ended Sept. 2015.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!